Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of April 27, 2025 • 3:00 AM ET
As of April 27, 2025 • 3:00 AM ET
Date/Time | Source | News Release |
---|---|---|
04/14/2025 09:35 AM EDT | Zacks | After Plunging -20.33% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB) |
04/11/2025 09:35 AM EDT | Zacks | After Plunging -19.7% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB) |
04/03/2025 04:06 PM EDT | SeekingAlpha | I-Mab Biopharma GAAP EPS of -$0.27 beats by $0.07 |
04/03/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, April 3rd, 2025 |
04/03/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - I-MAB |
04/02/2025 06:44 PM EDT | KlickAnalytics | IMAB - Historical Earnings Price Analysis |
03/27/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, March 27th, 2025 |
03/27/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - I-MAB |
03/21/2025 04:48 PM EDT | SeekingAlpha | I-Mab receives Nasdaq notice over non-compliance with minimum bid price rule |
03/20/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, March 20th, 2025 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.